MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Non-Motor Symptom In Young Onset Parkinson Disease as a Cause of Pharmacoresistence In Epilepsy

M. Awadh (Birmingham, United Kingdom)

Meeting: 2018 International Congress

Abstract Number: 1524

Keywords: Gastrointestinal problemsm(also see autonomic dysfunction)

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Non-Motor Symptoms

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: To report an interesting initial presentation of PD causing refractory epilepsy.

Background: A lady with refractory depression, presented with first seizure at age 42, reviewed after 3rd seizure 3 years later. Lithium was withdrawn and lamotrigine started, MRI, SDEEG were normal.

Methods: Seizures increased with complex partial seizures (CPS), no lateralizing symptoms. Patient was compliant on lamotrigine 200 mg bd. Lamotrigine was increased to 300 mg bd and levetiracetam added 1500 mg bd. She had a few months with no GTC seizures (used to be weekly) and seldom CPS (used to be a dozen/month), still low appetite, depression and weight loss. 6 months later, she had very frequent GTC seizures, with multiple hospital admission.

Results: Her written diary was tremulous micrographic with mild right bradykinesia and cogwheel rigidity with distraction. DaT was negative. A trial of co-beneldopa was consented 50/12.5 mg qds with marked improvement of her motor and mood symptoms, 2 CPS only over 3 months. Zonisamide was added in a small dose 100 mg od to help with parkinsonian tremor, subsequently no more seizures or tremor.

Conclusions: Gastroparesis might be one of the early non-motor symptoms of idiopathic Parkinson disease with subsequent sub-therapeutic absorption of various AEDs and recurrence of frequent clinical seizures. It is a difficult hardly sought cause for gastroparesis, however it is quite treatable cause with marked symptom improvement both for PD and epilepsy.

To cite this abstract in AMA style:

M. Awadh. Non-Motor Symptom In Young Onset Parkinson Disease as a Cause of Pharmacoresistence In Epilepsy [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/non-motor-symptom-in-young-onset-parkinson-disease-as-a-cause-of-pharmacoresistence-in-epilepsy/. Accessed July 1, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/non-motor-symptom-in-young-onset-parkinson-disease-as-a-cause-of-pharmacoresistence-in-epilepsy/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley